Monette Aujay

5.1k citations
34 papers · 3.3k indexed · 2 hit papers · h-index 19

Impact in

  • Hematology top 1%
    • Multiple Myeloma Research and Treatments
  • Virology top 5%
    • HIV Research and Treatment

Papers in

    • Multiple Myeloma Research and Treatments 8
    • Chronic Lymphocytic Leukemia Research 7

Monette Aujay

34 papers receiving 3.2k citations

Hit Papers

Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome 2007 · 542 citations
5421998202620072016250500750

Peers

Monette Aujay
Comparison fields: 5 of 119
  • Hematology 643
  • Virology 213
  • Molecular Biology 2.3k
  • Oncology 805
  • Genetics 151
Replace David J. Matthews with:
David J. Matthews United States
Joseph M. Covey United States
Arthur J. Chirino United States
Chris W. Sutton United Kingdom
Xiaoyun Lu China
Carlo Mischiati Italy
Linda K. Jolliffe United States
Jolanta Grembecka United States
Daniel A. Harki United States
Steven G. Nadler United States
Monette Aujay relative to David J. Matthews United States David J. Matthews's profile →
Citations per field
00.5×3.2×
David J. Matthews · 1×
Citations per year

Countries citing papers authored by Monette Aujay

Since Specialization
Citations

This map shows the geographic impact of Monette Aujay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monette Aujay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monette Aujay more than expected).

Fields of papers citing papers by Monette Aujay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monette Aujay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monette Aujay. The network helps show where Monette Aujay may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Monette Aujay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Monette Aujay Line = papers co-authored together Monette Aujay links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20235
2 202232
3 202015
4 202013
5 201837
6 201737
7 201634
8 201419
9 201134
10 201132
11 2010100
12 201066
13 2010163
14 2009494
15 2009270
16 20081
17 20084
18
Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome
Hit paper breakdown →
2007542
19 2000217
20
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus
Hit paper breakdown →
1998919

About Monette Aujay

Monette Aujay is a scholar working on Hematology, Genetics, Organic Chemistry, Oncology and Molecular Biology, having authored 34 papers that have together received 3.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (11 papers), Multiple Myeloma Research and Treatments (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Synthetic Organic Chemistry Methods (7 papers), Chemical Synthesis and Analysis (6 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Treatment and Pharmacology (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Hematology (643 citations), Virology (213 citations), Molecular Biology (2.3k citations), Oncology (805 citations) and Genetics (151 citations). Monette Aujay has collaborated with scholars based in United States, Greece and Germany. Frequent co-authors include Christopher J. Kirk, Mark K. Bennett, Francesco Parlati, Susan D. Demo, Marjory A. Snead, Gary J. Olsen, William G. Young, Ross Overbeek, Patrick V. Warren and Jay M. Short. Their work appears in journals such as Blood, Journal of the American Chemical Society, The Journal of Organic Chemistry, Cancer Research and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026